Big Mover Alnylam...

Pharmaceutical company surges 37% in premarket trading after positive test results for latest amyloidosis drug. [Trade of the Day Wake-Up Watchlist] Attention Traders: It’s Monday and our Lead Technical Tactician Nate Bear is giving you his weekly stocks to watch. Click the image below to see his picks for this week. Nate also has an exciting announcement for this week. On Wednesday, June 26, Nate will be going live to demonstrate how his [Daily Profits Scanner]( tool works. This is the exact way Nate finds A+ trade setups for consistent winning trades, and at this live event, he’s going to walk you through exactly how to use this tool for your own trading. Plus, he’ll also be giving out some bonus trades so you can spend less time researching and more time trading and getting on with your life. [Click here to sign up for the event this Wednesday at 2 p.m. EST.]( Good Morning Wake-Up Watchlisters! Break out the French press and get some ice (it’s hot out there). The markets remain hot as well. This morning stock futures were up with indexes entering the last week of June near record highs. The S&P nabbed a new record of 5,505.53 on Thursday, and the equity benchmark hit 0.6%. However, signs of exhaustion are creeping in as Nvidia had a selloff and fell 4% due to bearish patterns in recent trading. No matter what the markets do, our tacticians have strategies for consistent winning setups in [The War Room](. In fact, our Lead Fundamental Tactician Karim Rahemtulla has been crushing it off these recent record highs. So far this month, Karim has closed all 7 of his trades for winners for a 100% win rate, and last week he closed a 30.11% return on Draftkings in 66 trading days. [Click here to start following along with Karim’s trades in real-time today.]( Here’s a look at the top-moving stocks this morning. Alnylam Pharmaceuticals (Nasdaq: ALNY) Alnylam Pharmaceuticals is up 37.60% in premarket trading. This morning the pharmaceutical company reported positive topline results for its amyloidosis treatment drug. The study showed a statistically significant reduction in the composite of all-cause mortality and recurrent cardiovascular events during the double-blind period. [Write This Down: Tuesday, June 25 at 2 pm!]( [Gains]( Every Time The Government Releases Jobs, Inflation, GDP, and Other Economic Reports... Use The JOLTS Loophole for a Chance to Collect HUGE Overnight Profits! (Target up to 253%... 327%... Even 383% gains... OVERNIGHT!) [Don't Miss Our LIVE Trade]( ResMed. (NYSE: RMD) ResMed is down 10.56% in premarket trading after new competition entered the picture. Last week Eli Lilly reported that its weight loss drug Zapbound also reduced the severity of sleep apnea. ResMed makes devices that treat sleep apnea and COPD. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team [The Chance Meeting That Made Alex a Fortune]( Sometimes, the best investment advice comes from where you least expect it. For Alexander Green, it was from a casual chat during a basketball game 30 years ago. Uncover how this unexpected advice led to the biggest wins of Alex's career. [Click here to learn this secret.]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2024 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.